Interpace Biosciences, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Interpace Biosciences, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 7, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 8, 2025

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Mar 30, 2025

Annual report10-K

Q3 2024

Nov 4, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 1, 2024

Earnings release8-K

Q1 2024

May 9, 2024

Earnings release8-K

2023

Q4 2023

Apr 1, 2024

Annual report10-K

Q3 2023

Nov 8, 2023

Earnings release8-K

Q2 2023

Aug 9, 2023

Earnings release8-K

Q1 2023

May 12, 2023

Earnings release8-K

2022

Q4 2022

Mar 27, 2023

Earnings release8-K

Annual report10-K

Q3 2022

Nov 14, 2022

Earnings release8-K

Q2 2022

Aug 15, 2022

Earnings release8-K

Q1 2022

May 16, 2022

Earnings release8-K

2021

Q4 2021

Mar 31, 2022

Earnings release8-K

Annual report10-K

Q3 2021

Nov 10, 2021

Earnings release8-K

Q2 2021

Aug 10, 2021

Earnings release8-K

Q1 2021

May 11, 2021

Earnings release8-K

2020

Q4 2020

Apr 1, 2021

Annual report10-K

2019

Q4 2019

Apr 22, 2020

Annual report10-K

2018

Q4 2018

Mar 21, 2019

Annual report10-K

2017

Q4 2017

Mar 23, 2018

Annual report10-K

2016

Q4 2016

Mar 31, 2017

Annual report10-K

2015

Q4 2015

Mar 30, 2016

Annual report10-K

2014

Q4 2014

Mar 5, 2015

Annual report10-K